These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9893646)

  • 1. Continuation of the International Breast Cancer Intervention Study (IBIS).
    Cuzick J
    Eur J Cancer; 1998 Oct; 34(11):1647-8. PubMed ID: 9893646
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemoprevention of breast cancer with tamoxifen.
    Cuzick J
    IARC Sci Publ; 1996; (136):95-109. PubMed ID: 8791120
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trials referral resource. Breast cancer and prostate cancer.
    Brawley OW; Cheson BD; Phillips PH
    Oncology (Williston Park); 1996 Jan; 10(1):100, 102. PubMed ID: 8924360
    [No Abstract]   [Full Text] [Related]  

  • 4. Another view of tamoxifen.
    Napoli M
    Am J Nurs; 2001 Apr; 101(4):33. PubMed ID: 11301681
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chemoprevention of breast cancer. Clinical trials in pharmacological prevention].
    Ricart JJ
    Medicina (B Aires); 2004; 64(1):66-72. PubMed ID: 15034961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen or raloxifene for breast cancer chemoprevention: a tale of two choices--point.
    Jordan VC
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2207-9. PubMed ID: 18006908
    [No Abstract]   [Full Text] [Related]  

  • 7. Tamoxifen or raloxifene in postmenopausal women for prevention of breast cancer: a tale of two choices--counterpoint.
    Fabian C
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2210-2. PubMed ID: 18006909
    [No Abstract]   [Full Text] [Related]  

  • 8. Tamoxifen for the prevention of breast cancer in high-risk women.
    Sweeney FW; Newton WP
    J Fam Pract; 1999 Feb; 48(2):90-1. PubMed ID: 10037532
    [No Abstract]   [Full Text] [Related]  

  • 9. [Breakthrough in breast cancer chemoprevention].
    Kahán Z; Thurzó L
    Orv Hetil; 2003 Mar; 144(13):597-603. PubMed ID: 12728784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen and raloxifene may benefit women at high risk for breast cancer.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 Jul; 13(14):1-2, 5. PubMed ID: 12518771
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemoprevention of breast cancer. Impact of a new therapeutic strategy].
    Kattan J; Ghosn M
    J Med Liban; 1999; 47(5):284-5. PubMed ID: 10887527
    [No Abstract]   [Full Text] [Related]  

  • 12. Breast cancer prevention with tamoxifen.
    Haden K; Santen R
    Lippincotts Prim Care Pract; 2000; 4(4):434-40. PubMed ID: 11261120
    [No Abstract]   [Full Text] [Related]  

  • 13. Raloxifene works as well as tamoxifen in preventing invasive breast cancer.
    Mayo Clin Womens Healthsource; 2006 Oct; 10(10):3. PubMed ID: 16977270
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemoprevention of breast cancer.
    Mahon SM
    Clin J Oncol Nurs; 2004 Aug; 8(4):421-3. PubMed ID: 15354932
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemoprevention of breast cancer.
    Dalton RR; Kallab AM
    South Med J; 2001 Jan; 94(1):7-15. PubMed ID: 11213947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary prevention of breast cancer in women with an increased risk for breast cancer--a prospective, randomized, double-blind study (NSABP-P1 study)].
    Reichert D; Illiger HJ
    Strahlenther Onkol; 2000 Jan; 176(1):43-4. PubMed ID: 10650836
    [No Abstract]   [Full Text] [Related]  

  • 17. Breast cancer prevention. New options for patients and clinicians.
    Willett LR; August DA; Carson JL
    N J Med; 2002 Sep; 99(9):27-34. PubMed ID: 12244704
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemoprevention trends in breast cancer.
    Lazzaro M; Mizell V; Thompson M; Weber D
    Adv Nurse Pract; 1998 Nov; 6(11):26-8, 33-4, 74. PubMed ID: 9919058
    [No Abstract]   [Full Text] [Related]  

  • 19. Inherited and acquired risk factors for venous thromboembolic disease among women taking tamoxifen to prevent breast cancer.
    Duggan C; Marriott K; Edwards R; Cuzick J
    J Clin Oncol; 2003 Oct; 21(19):3588-93. PubMed ID: 14512389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction.
    Melnikow J; Paterniti D; Azari R; Kuenneth C; Birch S; Kuppermann M; Nuovo J; Keyzer J; Henderson S
    Cancer; 2005 May; 103(10):1996-2005. PubMed ID: 15825209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.